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Introduction: Offspring of mothers with hypertensive disorders of pregnancy (HDP) are at increased future risk of hypertension, cardiovascular disease and stroke. The pathophysiological mechanisms for this association are not well understood, but microvascular abnormalities and in particular capillary rarefaction (CR) have been implicated. In a previous pilot study, we found that infants born preterm to HDP mothers have significant CR at birth.
Methods: We studied 111 infants born to mothers with an HDP (90 born at term (T-HDP) and 21 born pre-term (PT-HDP) and compared them to 278 normal birth weight infants born at term to normotensive mothers (control group). We used intravital capillary microscopy to measure basal i.e. functional (BCD) and maximal i.e. structural (MCD) capillary densities and BP at birth, 3 months, 6 months and 12 months. We report here BP and capillary density results at birth.
Results: PT-HDP infants had a significantly higher BCD (mean difference 12.62 cap/field; p = 0.001) and (mean difference 17.26 cap/field; p < 0.001) compared to T-HDP infants and controls respectively. T-HDP infants also had a significantly higher BCD (mean difference 4.64, cap/field; p = 0.012) compared to control infants). PT-HDP infants also had higher MCD (mean difference 10.53 cap/field; p = 0.003) and (mean difference 13.67 cap/field; p < 0.001) respectively compared to T-HDP and control infants. Systolic BP was significantly higher in PT-HDP infants compared to control infants (mean difference 7.19 mmHg; p = 0.032). There were no significant differences in diastolic BP.
Conclusions: PT-HDP infants have a significantly higher systolic BP at birth compared to infants of normotensive mothers. Furthermore, PT-HDP have, contrary to our pilot study, a significantly higher BCD and MCD compared to NBW infants of normotensive mothers. Further follow-up studies of these infants are required to investigate the crucial role of microcirculatory abnormalities in the pathogenesis of future hypertension. Introduction: Haemodynamic determinants of hypertension in young adults include increased stroke volume and arterial stiffness [1] . The aim of the present study was to examine the contribution of left ventricular ejection, arterial stiffness and systemic vascular resistance to hypertension in children with essential hypertension.
Methods: A total of 81 children aged 7 to 18 years (mean age 14 years) including 31 with hypertension and 50 age matched normotensive children were recruited from the paediatric hypertension clinic and local community. 18 (58.1%) hypertensive subjects were taking antihypertensive medication. Non-invasive aortic flow velocity and central blood pressure were measured by Doppler sonography and carotid tonometry system respectively. Aortic pulse wave velocity was calculated using the sum of squares method [2] .
Results: Compared with normotensive subjects, those with essential hypertension had significantly higher central pulse pressure (43 ± 15 vs. 29 ± 8 mmHg, mean ± SD), heart rate (81 ± 15 vs. 73 ± 11 bpm), and cardiac output (5.4 ± 2.0 vs. 4.3 ± 1.2 L/min), P < 0.01 for all comparisons. There was a trend toward increased stroke volume in hypertensive subjects, but not significantly different from normotensive subjects. However, there were no differences in augmentation pressure, reflection index or systemic vascular resistance between the two groups. The increase in central pulse pressure was explained by an altered pattern of ventricular ejection (initial flow increased from 1.13 to 1.26 m/s, P = 0.008) and increase in aortic pulse wave velocity from 2.5 to 3.4 m/s (P = 0.001).
Conclusions: These results suggest that increase in central pulse pressure in hypertensive compared to normotensive children is explained by an increase in arterial stiffening and altered pattern of ventricular ejection.
Disclosure: Introduction: Hypertension is the leading risk factor for cardiovascular disease (CVD). A common C677T polymorphism in the folate metabolising enzyme, methylenetetrahydrofolate reductase (MTHFR) is associated with an increased risk of hypertension by 24-87%. Randomised controlled trial evidence from our Centre has demonstrated that riboflavin, the MTHFR cofactor, can lower blood pressure (BP) by 5-13 mmHg, an effect confined to homozygous individuals (TT genotype). To date, our trials have focused on peripheral BP; however, central pressure, which is more closely correlated with CVD risk, may offer further insight into the role of this gene-nutrient interaction in BP. The aim of this study was to investigate both peripheral and central BP in apparently healthy adults, stratified by MTHFR genotype. Methods: Adults aged 18-60 years recruited from workplaces across Northern Ireland were screened for MTHFR genotype. Individuals with TT genotype were ageand sex-matched to CC/CT controls. Brachial BP and central BP (SphygmoCor®, AtCor Medical, Australia) were measured. A blood sample and lifestyle information were also obtained.
Results: Preliminary results (n 409) confirm elevated BP in individuals with the MTHFR 677TT genotype compared to CC/CT controls (systolic BP 134.7 ± 13.8 mmHg vs. 129.7 ± 12.4 mmHg, P < 0.001; diastolic BP 81.6 ± 9.5 mmHg vs 79.7 mmHg ± 8.9 mmHg, P = 0.023). The MTHFR 677TT genotype group had significantly higher central systolic BP (119.4 ± 11.8 vs 116.7 ± 10.9 mmHg, P = 0.018), central pulse pressure (P = 0.006) and central mean pressure (P = 0.011) compared to the non-TT group. No significant differences for central diastolic BP, pulse pressure amplification, pulse pressure ratio and augmentation index were observed. Introduction: Genome-wide association studies (GWAS) have identified over 800 single nucleotide polymorphisms (SNPs) associated with blood pressure (BP). The biological mechanisms of their associations with BP are not clear. We hypothsised that a significant proportion of these variants operate through effects on gene expression (e), alternative splicing(s) and methylation(m) in the human kidney.
Methods: We collected 430 human kidneys from 5 studies. Transcriptome profiling was performed by nextgeneration RNA-sequencing. Quantification of splicing ratios was performed using LeafCutter. DNA methylation levels were measured using Infinium Human Methylation450 array and EPIC array. Genotyping was collected by Infinium Human CoreExome-24 BeadChip array or Affymetrix SNP 6.0 array. We conducted cis-quantitative trait locus (QTL) analyses on the three layers of kidney omics followed by colocalisation and Mendelian randomisation (MR) analyses.
Results: We discovered a total of 18,201 renal genes, 50,982 intron excision clusters (IECs) and 374,826 CpG sites in human kidney. After correction for multiple testing, we identified 7348 genes (kidney eGenes), 6799 IECs (kidney sIECs) and 34,913 CpG sites (kidney mCpG) from cis-QTL analyses. We uncovered that 58% BP GWAS loci have at least one functional (expression, splicing or methylation) signature. In 31% of these BP GWAS loci, the expression, splicing or methylation target share the same causal genetic variant with BP. MR further confirmed 98 kidney targets as causally related to BP.
Conclusions: We uncovered the identity of renal genes and molecules operating as the regulators of BP. These genes are excellent targets for the development of new therapeutic strategies.
Disclosure [1] . Accordingly, we reported that young SA men show blunted reactive hyperaemia and forearm vasodilator responses to mental stress relative to WE men [2] . Whether these responses are blunted in SA women and whether prostaglandins (PGs) contribute to either response in SAs is unknown. Methods: In Group 1 (9 WE, 9 SA women; 18-26 years), we recorded mean arterial pressure (MAP) and forearm blood flow (FBF) during reactive hyperaemia (RH) and 5 sound stress stimuli (S1-S5; 100 dB, 2 KHz, 30s at 5-10 min intervals): forearm vascular conductance (FVC); FBF/MAP). In Group 2 (14 SAs; 6 men/9 women; 19 WEs:10/9), this protocol was performed without and after cyclooxygenase (COX) inhibition (aspirin, 600 mg p.o).
Results: In Group 1, RH was similar in WE and SA women (Δ FVC: +0.28 ± 0.03 vs +0.32 ± 0.02 conductance units (CU)). However, S1-S5 evoked forearm vasodilatation in WE women, but mean vasoconstriction in SA women (ΔFVC: +0.005+0.003 vs −0.009 ± 0.004CU), more individual SA women showing forearm vasoconstriction (63.6 vs 33.3%). In Group 2, SA men and women who showed forearm vasoconstriction (vasoconstrictors) to S1-S5 showed blunted RH relative to vasodilators (+0.45 ± 0.05 vs +0.31 ± 0.02CU, p = 0.03). Further, COX inhibition had no effect on RH, or SS1-5 on vasoconstrictors to SS1-5 (RH: 0.31 ± 0.02 vs 0.38 ± 0.02CU; SS1-5: −0.012 ± 0.005 vs −0.033 ± 0.005CU), but attenuated RH and SS1-5 in vasodilators to SS1-5 (RH: 0.45 ± 0.05 to 0.30 ± 0.03CU, p = 0.05; S1-S5: 0.011 ± 0.005 vs 0.003 ± 0.002CU, p = 0.004).
Conclusions: Reactive hyperaemia, which is endothelium-dependent, is of similar magnitude in young SA and WE women. However, SA women and men show blunted forearm vasodilatation or in the majority of individuals, predominating vasoconstriction to repeated environmental stress. Those SAs who show vasodilatation may be protected by vasodilator PGs, but those who show vasoconstriction may be particularly at risk of stressinduced CVD.
Disclosure: None References: Introduction: Animal data suggest that the skin may protect against the adverse haemodynamic effects of dietary salt by storing sodium in an osmotically inactive form, bound to glycosaminoglycans in the extracellular matrix. However, to date this novel pathway has not been comprehensively studied in humans.
Methods: 85 healthy volunteers (37 males, 48 female) under 50 years were recruited into a double-blind parallel study design. Participants underwent a one-week run-in period to standardise dietary salt intake before random allocation to either lactose placebo or 2.5 mg indapamide diuretic daily for eight days.
Total body water (TBW) quantification, haemodynamic measurements, and skin biopsies were performed before and after treatment. Peripheral blood pressures were measured after 5 min seated rest. Pulse wave velocity (PWV) was measured using SphygmoCor, and stroke volume (SV) and cardiac output (CO) were measured by inert gas rebreathing.
5 mm skin biopsies were taken from the lower back using sodium-free lignocaine. Biopsies were freeze-dried to establish water content, whilst sodium content was quantified using inductively coupled plasma-optical emission spectroscopy. Glycsosaminoglycan content was assessed by qPCR. Data were analysed using repeated measures ANOVA.
Results: Following indapamide treatment, skin sodium fell by 10% (p = 0.004) with no reduction in skin water content, compared to placebo. There were no significant differences in blood pressure or PWV between groups. TBW, SV, and CO were significantly reduced by indapamide compared to placebo (p < 0.001, p = 0.007, p = 0.009, respectively), whilst systemic vascular resistance increased (p < 0.001). mRNA expression of glycomsaminoglycan synthetic enzymes were reduced (p < 0.05).
Conclusions: A diuretic-induced reduction in skin sodium, without commensurate water loss, suggests release of sodium from osmotically inactive skin stores, while the corresponding drop in glycosaminoglycan synthetic enzyme expression suggests these stores are regulated by glycosaminoglycans in humans. This is the first comprehensive evidence of glycosaminoglycan-regulated non-osmotic skin sodium storage in humans.
Disclosure Introduction: Chronic kidney disease (CKD) is a leading risk factor for cardiovascular events and mortality [1] . Hypertension and arterial stiffness are both considered fundamental intermediaries to cardiac disease in this population yet existing hypertension is widespread in CKD [2] . It is uncertain whether arterial stiffness is related to a reduction in glomerular filtration rate or the many co-morbid conditions including hypertension which accompany CKD. EARNEST was a multi-centre prospective controlled study designed to investigate the haemodynamic effects of an isolated reduction in kidney function due to uninephrectomy. Methods: Living kidney donors and healthy controls were recruited from seven UK centres. Inclusion and exclusion criteria for donors and controls were set in accordance with national living kidney donor criteria. Participants underwent ambulatory blood pressure (using the Mobilo-O-Graph®) and assessment of arterial stiffness (using the SphygmaCor) at baseline and 12 months.
Results: A total of 469 participants were recruited, of which 306 (138 controls and 168 donors) attended follow up. There were no differences between donors and controls in either ambulatory day systolic blood pressure (123.78 ± 9.77 vs 122.90 ±11.66 mmHg, p = 0.534) or ambulatory day diastolic blood pressure (78.90 ± 7.97 vs 77.89 ± 8.87mmHg, p = 0.358) at 12 months. There were also no significant differences in ambulatory night blood pressures.
Mean change in pulse wave velocity (PWV) was not significantly different in donors compared to controls (+0.299 vs +0.122 m/s, p = 0.120). In a multivariable model, kidney donation was not independently associated with a change in PWV (β coefficient 0.17 (confidence interval −0.049-0.404), p = 0.126).
Conclusions: At 12 months after nephrectomy, there was no significant change in ambulatory peripheral blood pressure or pulse wave velocity. Living kidney donors can be reassured that at least at one year after donation there is no evidence of a rise in peripheral blood pressure or pulse wave velocity.
Disclosure: Barts Health NHS Trust, London, United Kingdom, 3 Tarilian Laser Technologies, Welwyn Garden City, United Kingdom, Introduction: A newly developed non-invasive cuff-less BP sensor enables high fidelity direct beat-to-beat measurement of BP in digital format using patented optoelectronic methods without need for calibration, compression or energy entering the body. The sensor's main components comprise a light emitting diode (LED) utilising a semiconductor light source, a waveguide, a photodiode and a flexible button which is placed on the skin over the radial artery all housed within a strap. We evaluated the accuracy of this device compared to an intra-arterial BP catheter according to the ISO-81060-2:2013 standard.
Methods: Patients were recruited who were indicated to receive an invasive radial arterial BP catheter as a standard of clinical care. Non-invasive BP was measured with the deviceunder-test which was applied in the post-operative period to the contralateral wrist to the radial arterial line. The reference BP ranges were determined from the recording of the invasive BP for a duration of at least 30 s that included the period of the determination of the device-under-test for which 10 BP determinations per patient were recorded.
Results: In total 12 adult men and 6 women with mean age of 59 years, BMI < 35 kgm2 and in sinus rhythm were studied. [1] . We investigated whether this is also the case in children with hypertension. Methods: Transthoracic echocardiography and carotid tonometry were performed in 31 children with essential hypertension and 50 age matched normotensive subjects. Left ventricular (LV) cavity and epicardial volumes was obtained from 4-chamber view using Tomtec wall tracking analysis. The ratio of mitral valve Doppler early flow (E) and tissue Doppler mitral annulus movement (e') was used (E/e') as a measure of diastolic function. Time-varying ejection phase myocardial wall stress (MWS) was calculated from LV volumes and central aortic pressure derived from carotid tonometry [2] . Time to onset of relaxation (TOR) was defined as time to peak MWS over ejection time. Pulse wave velocity (PWV) was calculated from aortic arch to abdominal aorta using pulsed Doppler from echocardiography.
Results: Hypertensive children were of similar age and BMI compared to normotensive children. Hypertensive children had increased LV mass index (p = 0.001) and relative wall thickness (p < 0.001) suggestive of concentric remodelling. There was no difference in LV systolic measures including ejection fraction and global longitudinal strain between hypertensives and normotensives. However, hypertensives had higher E/e' ratio (6.4 ± 1.1 vs 5.5 ± 1.0, p < 0.001), PWV (5.1 ± 1.5 vs 4.3 ± 0.9 m/s, p = 0.023) and prolonged TOR (32.5 ± 9.2 vs 28.8 ± 5.6%, p = 0.027) and elevated mean MWS (409.7 ± 93.1 vs 336.6 ± 86.6 kdynes/cm 2 , p = 0.001) than normotensives. TOR was positively associated with E/e' ratio (β = 0.277, p = 0.01) with or without adjustment for age, sex, BMI, mean arterial pressure, HR, left ventricular mass and antihypertensive treatments.
Conclusions: In children with essential hypertension and normal systolic function, pre-clinical diastolic dysfunction is associated with prolonged systolic contraction.
Disclosure: None References: Methods: Sixteen healthy non-obese males were recruited (mean±SD age 29 ± 6 years). All participants were overfed approximately 1000 kcal/day, alongside their normal diet, for 6-8 weeks, until a 5 kg weight gain was achieved and held stable for at least 1 week. Detailed anthropometric characteristics, BP, CO and PVR were assessed at baseline and at completion of the overfeeding intervention.
Results: Overfeeding significantly increased body weight (6.11 ± 3.08 kg, P < 0.001), lean mass (3.61 ± 3.40 kg, P = 0.001) and fat mass (2.64 ± 2.89 kg, P = 0.002). The increases in systolic BP (2 ± 9 mmHg) and diastolic BP (2 ± 6 mmHg) were not significant (P < 0.2 for both) and the increase in heart rate was of borderline significance (5 ± 10 bpm, P = 0.055). There was a significant increase in CO (0.81 ± 1.35 L/min, P = 0.031), which was accompanied by a decrease in PVR (129 ± 205 dynes.s.cm 5 , P = 0.024). Dichotomising individuals based on a systolic BP response to weight gain ≥5 mmHg (BP responders) revealed small differences vs non-responders in the change in CO (+1.34 ± 0.99 L/min vs +0.4 ± 1.50 L/min) and PVR (−111 ± 142 dynes.s.cm 5 vs −143 ± 251 dynes.s.cm 5 ), although neither was statistically significant.
Conclusions: Modest weight gain in healthy, non-obese men is associated with increases in lean and fat mass. A compensatory reduction in PVR in response to elevated cardiac output is likely to explain the lack of change in BP. Examining 'BP responders' versus 'BP non responders' is likely to provide useful insights into obesity-associated hypertension in a larger trial.
Disclosure Results: Significant reductions in SBP were found at 12-weeks and continued to 48 weeks. Sub-groups showed the following reductions from baseline: PCI (n = 90) −7.2 mmHg at 12 weeks, −8.3mmHg at 48 weeks; CABG (n = 33) −8.4 mmHg at 12 weeks, −12.9 mmHg at 48 weeks; HTN (n = 166) −9.5 mmHg at 12 weeks, −10.3 mmHg at 48 weeks; Arrhythmia (n = 64) −10.1 mmHg at 12 weeks, −13.8mmHg at 48 weeks (all p < 0.01); Valvular (n = 34) −7.9 mmHg at 12 weeks, −9.8 mmHg at 48 weeks; Non-cardiac (n = 47) −6.6 mmHg at 12 weeks, −4.2 mmHg at 48 weeks mmHg (both p < 0.05).
97.5% of participants completed the initial 12-week programme with 35.1% opting to stay for the full 48-weeks.
Conclusions: A 12-week lifestyle intervention significantly reduced SBP, and this effect was maintained or further improved at 1-year. The effect was most powerful in cardiac populations.
Disclosure: Introduction: Hypertensive patients benefit from early control of BP to ameliorate end-organ damage. However, access to specialist care for hypertensive patients can involve long waiting times, travel and expense for patients and CCGs. In 2016, we developed a virtual hypertension clinic in collaboration with Camden CCG to provide remote advice to GPs and triage hypertension patients to community nurse led or hospital clinics. Methods: Two consultant nephrologists (SBW, JMC) review referrals made to the virtual hypertension clinic on the EMISWeb platform every week. EMISWeb is an electronic patient record system used to record all the clinical observations, measurements and investigation results for all patients seen in Camden primary care. At the virtual clinic, the referral, and the patient's records can be viewed with clinic BP and ABPM measurements, medications (and number of collected prescriptions), biochemistry and other special investigations and medical history. A treatment plan is written at the time of review for the GP. This may be for: 2 Simple advice with a plan for pharmacotherapy with BP goals.
• Direct triage to a community hypertension nurse specialist clinic for longer consultations than possible for GPs. This includes motivational interviewing, stress workshops, lifestyle and dietary advice.
• Direct triage to hospital clinic for patients who require investigation for secondary hypertension or adherence testing.
Results: Since 2016, 846 patients (median age 43 years, 53% male) were reviewed.
Referral indications: Age of onset <40yrs 57%, Resistant hypertension 28%, Unusual hypertension 11%, Other 3%. Outcomes: 35% discharged with treatment plan, 30% triaged to community nurse-led clinic, 24% triaged to hospital clinic, 11% other outcome. The virtual hypertension clinic provided a minimum cost saving of £112.23 per patient attendance compared with traditional outpatient care.
Conclusions: Implementation of a virtual hypertension clinic offers a cost-effective, rapid referral mechanism for specialist advice, patient assessment and triage.
Disclosure Introduction: Differences in systolic blood pressure (BP) between arms are associated with excess mortality and cardiovascular events. A systolic inter-arm difference (IAD) has been attributed to subclavian stenosis and arterial stiffening, but the patho-physiological basis of IAD has not been clearly established. We investigated cross-sectional associations of systolic IAD within the INTERPRESS individual participant data (IPD) Collaboration to gain further insight.
Methods: We explored univariable and multivariable models, examining cross-sectional associations of IAD with markers of cardiovascular risk, using hierarchical IPD linear regression, with random effects for study. IAD was calculated from a single sequential pair of BP readings. Model comparison using Aikeke's information criterion (AIC) and likelihood ratios (LR) was undertaken.
Results: The INTERPRESS-IPD Collaboration includes over 57,000 IPD records from 24 studies [mean (SD), age 60.3 (12.5); 47% female; mean BP 139/81 (22/12)]. Baseline prevalences of systolic IADs ≥10 mmHg and ≥15 mmHg were 28.2% and 11.1%, respectively. Using complete case IPD (n = 43,488; 22 cohor\ts), IAD was larger in females (p = 0.002), with smoking (p = 0.04), increasing age (p = 0.05), body mass index (p < 0.001), systolic BP (p < 0.001) and hypertension (p < 0.001). IAD was smaller for African American (p = 0.04) and Hispanic American (p < 0.001) participants compared to White ethnicity.
Using all available IPD, goodness of fit improved after taking account of pre-existing cardiovascular disease (LR p = 0.004; n = 41,664), addition of pulse pressure (LR p < 0.001; n = 33,844) or adjustment for renal disease (LR p < 0.001; n = 15,541). AIC was non-discriminatory between models.
Conclusions: This analysis confirms independent crosssectional associations of systolic IAD with recognised cardiovascular risk markers. Findings are consistent with hypotheses that IAD reflects pathological change in the circulation. IAD risk factors are those associated with both arterial stiffening and occlusive arterial disease; both processes may contribute to IAD. These findings support further hypothesis generation and justify studies to further elucidate the aetiology of IAD.
Disclosure: None Introduction: Hypertension has been reaffirmed as the single biggest risk factor contributing to death rates worldwide. General practitioners play a crucial role in management; however, this challenge may also present to the acute physician in the form of a 'hypertensive crisis'. Currently, there is little data examining such patients presenting to acute medical services. We aimed to determine whether patients referred to either the ambulatory care unit (ACU) or acute medical Unit (AMU) with 'hypertension', are true hypertensive crises, to characterise this group of patients demographically, and to determine whether their management is in accordance to existing guidance.
Methods: A retrospective analysis of case notes and electronic records of patients identified as having 'Hypertension' as their primary diagnosis over a 12 month period (Jan 2017-Dec 2017) was undertaken. Data collected included source of referral, blood pressure (BP) at presentation, investigations undertaken, treatment, and followup arrangements.
Results: Fifty-eight patients were included in the audit. Mean age was 62 years with age range of 29-86 years. 51.7% were referred from primary care, and 34.4% from the emergency department (ED). Mean systolic BP at presentation was 217.3 mmHg and mean diastolic BP 116 mmHg. Most patients met criteria for a 'Hypertensive crisis' (94.7%). Investigations for end-organ damage were undertaken inconsistently (e.g. fundoscopy 36.2% vs. renal function tests 82.7%). Although only 69% were treated in accordance to NICE guidelines 2 , reasons such as drug intolerance were not always recorded. Most (95%) were followed up (e.g. by GP or specialist hypertension clinic).
Conclusions: Referrals to ACU and AMU for hypertension were appropriate. Although investigations to assess end-organ damage were inconsistently performed, most were referred for follow-up where these may have been subsequently undertaken. Further work is needed to assess outcomes in such patients, including efficacy of treatment in achieving BP control.
Disclosure: None Introduction: Changes in hypertension guidelines have resulted in an increase in secondary care referrals and consequent delays in first clinic appointments. A nurse led service was established to undertake targeted investigations prior to clinic attendance in order to streamline the patient journey. We proposed a virtual clinic process whereby these results were reviewed by senior clinicians and so reduce unnecessary out-patient clinic appointments.
Methods: We reviewed referrals to the Glasgow Blood Pressure Clinic (GBPC) between December 2016 and March 2017 when all patients were appointed directly to clinic. We compared these with referrals between September and December 2018 which were reviewed in the virtual clinic. We collected data including reason for referral, time to first appointment and new appointments saved as a result of this process.
Results: There were 142 referrals to the GBPC between December 16-March 2017. 64.8% (92) of referrals were for specialist review, 14.8% (21) were for ambulatory blood pressure monitoring (ABPM) and 19.7% (28) were for resistant hypertension or patients with multiple intolerances. 1 patient was discharged prior to clinic review following ABPM review. The remaining 141 patients were all given clinic appointments and 22.5% of referrals were discharged from first clinic visit.
There were 94 referrals between September and December 2018. 62.8% (59) of referrals were for specialist review, 28.7% (27) were for ABPM and 7.5% (7) were for resistant hypertension or patients with multiple intolerances. 36% (34) of referrals were discharged from the service prior to clinic attendance. GPs were provided with ABPM results, reasons for discharge from the service and advice where appropriate.
Conclusions: Review of ABPM results prior to clinic attendance has led to a reduction in the number of unnecessary new patient clinic appointments and more timely management of hypertension referrals from primary care.
Disclosure: None P-03 Missed opportunities: An audit of blood pressure measurements in the cardiology outpatient department The aim of this audit was to assess whether blood pressure (BP) was being measured in cardiology outpatient clinics at a District General Hospital and when raised blood pressures were identified, were they acted on appropriately.
Methods: 200 consecutive cardiology outpatient clinic records of patients seen between 1st and 12th September 2017 were accessed from an electronic database to assess whether BP had been measured and what action had been taken if hypertension was identified.
Results: All patients had BP measured by a nurse but only those seen by a hypertension specialist had further measurements. 33% (66) had raised BP (≥ 140/90, or ≥ 150/ 90 if age ≥ 80 years). Of these 61% (40) had further management or were referred to their GP for this.
Conclusions: There was a high prevalence of BP elevation in these cardiology outpatients who are more likely to benefit from assessment and possible intervention. The opportunity to manage raised BP, although measured universally was neglected in a significant number of patients. It is appropriate to ensure that cardiologists recognise the importance of acting upon all raised BP measurements to minimise the avoidable consequences of hypertension in their especially vulnerable patients.
Disclosure: none Database clarification:The database used was the Evolve system to look at clinic letters. With regards to the conclusions all the conclusions were made from the results section of the abstract with exception of saying their was a high prevalence, however this can be concluded by the prevalence of 33% in the outpatient population compared to the UK average of estimated 18% according to the Health survey England in 2017.
P-04 Prevalence of masked hypertension in treated and untreated clinically normotensive patients
Kamran Basharat Introduction: Masked hypertension (MH) and masked uncontrolled hypertension (MUCH) are both associated with increased cardiovascular disease risk. However, few data is available on the prevalence MH and MUCH in the UK population. Likewise, there is limited data on the characteristics of the MH subtypes of masked daytime hypertension (MDH) and masked nocturnal hypertension (MNH).
Methods: In this retrospective study, we analysed the data of 177 individuals with non-elevated clinic BP (CBP < 140/90 mmHg) who attended our clinic for 24-h ambulatory BP monitoring (ABPM). 105 of these individuals were taking antihypertensive medication whilst 72 were not. A Spacelabs 90217 BP Monitor was used to asses ambulatory BP (ABP). Individuals with a non-elevated CBP, nonelevated daytime ABP (BP < 135/85) and non-elevated nocturnal BP (BP < 120/70) were classified as having sustained normotension (SN), or controlled BP if on antihypertensive medication. Individuals with a non-elevated CBP but with an elevated daytime ABP (SBP≥135 and/or DBP) ≥85) were diagnosed with MDH, or masked uncontrolled daytime hypertension (MUCDH) if taking antihypertensive medication. individuals with a non-elevated CBP, a non-elevated daytime ABP, but an elevated nocturnal ABP (SBP ≥120 and/or DBP≥70) were diagnosed as having MNH, or MUCNH if taking antihypertensive medication.
Results: Of those untreated, 40 patients (55.6%) were diagnosed with MH (age 42.3 years, 57.5%men). Of those taking medication, 74 patients (70.5%) were diagnosed with MUCH (age 53.4 years, 51.4%men). Smoking history was significantly higher in MDH and MNH groups. The proportion of individuals with high-normal CBP (≥130/85 but <140/90) was also significantly higher in MDH (p < 0.001), MNH (p < 0.048) and MUCDH groups (p < 0.001).
Conclusions: The prevalence of MH and MUCH is high in individuals attending a specialist hypertension centre. Our findings suggest the need for the acknowledgement of these entities by UK guidelines, and suggest 24h-ABPM (rather than day-time) screening in individuals with highnormal BP and in smokers.
Disclosure: None [1] . The prevalence of HTN in OSA patients ranges from 35 to 80% and appears to be influenced by OSA severity [2] . Severe untreated OSA has been linked to fatal and nonfatal cardiovascular events, and all-cause mortality [3] . Hypertension secondary to OSA is underrecognised and undertreated. Methods: We undertook a clinical audit as part of quality improvement project with retrospective review of electronic records in our Trust. NICE and ESH hypertension guidelines used as standard.
Results: 423 patients referred for sleep study were studied and 75% confirmed to have OSA of which 53% with moderate to severe OSA.105 patients with diagnosis of severe OSA were analysed further and 62 (59%) patients had diagnosis of hypertension.43 patients with severe OSA had no screening for HTN. 11 patients with diagnosis of hypertension and severe OSA were not on any medical treatment. 12 patients were not on optimal target blood pressure control. 60% of patients who were taking 3 or more antihypertensive medications were not on target and not under specialist care.
Conclusions: This clinical audit highlights that patients with OSA are under-recognised and undertreated for their hypertension. Currently we are undertaking quality improvement project on how to improve awareness, develop screening and referral pathways for these patients. Further study is required for guidance on management of OSA with HTN.
Disclosure: [1] . UK guidelines are due to be addressed in 2019. We aim to compare blood pressure differences in PLWH with patient cohorts accessing other healthcare settings (renal clinic and general practice (GP).
Methods: Prospective data collection from 4 HIV units, GP surgery, and a renal unit (CKD stage 3-5 excluding dialysis patients) over one week. Age, sex, BP, BP medication, previous heart attack (MI) or stroke (CVA), years on antiretroviral therapy (ART) were collected.
Results: 431 people included, 271 PLWH (mean 47 years, mean ART duration 11 years), 41 from GP (59 years), 119 from renal (56 years). 265 (61%) male, 235 (55%) white, 137 (32%) black African/Caribbean, Asian 35 (8%).
Of 100 people on BP medication 56% had uncontrolled BP (>140/90). Mean systolic BP in PLWH 132; comparable to GP (134; p = 0.78) but lower than renal (139; p < 0.01). 13% of GP patients were on BP medications; 15% of PLWH, 28% in renal. In PLWH 45% were uncontrolled. 62 (29%) PLWH not on medication had high BP (>140/90) which would increase to 133 (62%) using ACC guidelines. Prevalence of MI/CVA was higher in PLWH (5.5%) compared to GP (4.9%).
Conclusions: PLWH represent a vulnerable group of younger patients with an increasing incidence of cardiovascular risk. They have high prevalence of undiagnosed hypertension and, of those on BP treatment, a significant number were uncontrolled. We advocate using the ACC guidelines to diagnose and treat PLWH to reduce cardiovascular morbidity and mortality. Introduction: Ante-and intra-partum preeclampsia is a common condition that is managed in all obstetric departments nationwide. Postpartum pre-eclampsia is significantly less common, therefore its management is less clearly documented and less evidence-based. The treatment is either using the drugs used during pregnancy, or the ones suggested by NICE-BHS guidelines. Methods: Two female patients, with no history of preeclampsia, were noted to be suffering from refractory hypertension post-partum. Their hypertension did not resolve with conventional obstetric medical management, including labetalol, hydralazine and magnesium sulphate, therefore endocrinological advice was sought. A case report series was formulated to highlight the successful outcomes, good clinical practice, and the need for improved knowledge and guidelines surrounding post-partum preeclampsia.
Results: We found that in women who are not breastfeeding, their hypertension, resistant to other agents, responded better to cardio-selective beta-blockers, such as bisoprolol. Both patients had their hypertension successfully managed with cardio-selective beta-blockers +/− calcium channel blockers and alpha-antagonists, and have been well since. Women who are breastfeeding should be treated with the drugs, which are known to be safe for the infant. Women who are not breastfeeding, may be treated with cardio-selective beta-blocker based therapy, which will be helpful due to their once daily dosing to fit in to the busy life of a parent.
Conclusions: Cardio-selective beta-blocker based therapy may benefit young women with post-partum pre-eclampsia. Very little is understood surrounding the pathophysiology of post-partum pre-eclampsia and its management, therefore making it a very difficult disease to manage when seen in the clinical setting. Further research in the field is required to better understand the nature of the disease, and to improve the quality of care we can offer our patients.
Disclosure: None The Akuba Foundation, Manchester, United Kingdom, 4 Queen Mary University of London, London, United Kingdom Introduction: In 2017, a patient from the Hypertension clinic at Manchester Royal Infirmary requested assistance with the delivery of care for pregnant women with BP-related complications in Western Ghana. A fact-finding team was assembled in 2018, comprising hypertension physicians (AG, PR), a haematologist (JT), business strategy consultant (GS) and a charitable sector startup executive (JO). We gratefully acknowledge funding contributions from BIHS, Manchester University Social Responsibility programme and the generosity of our local hosts.
Methods: We spent 5 days in the Western Region of Ghana, visiting rural villages to evaluate local healthcare provision. We met with health visitors and midwives and learned of their experiences and outlooks for the treatment of (pre)eclampsia. We visited three hospitals, met with management teams and clinicians who deliver maternity care, and we attended a novel 'Pregnancy School'.
Results: We will present an overview of the current provision for hypertension care in the setting of pregnancy within Western Ghana. Qualitative evaluation with midwives revealed enthusiasm for health promotion, and good levels of education and awareness, but concerns regarding parallel pathways for pregnancy management by untrained 'Traditional Birthing Attendants (TBA), the availability of equipment and medication, and the capacity for patients to attend care due to lack of affordable transport. We describe innovative recent schemes to facilitate collaboration and cross-talk between the TBA approach and modern obstetrics and midwifery.
Conclusions: The sub-optimal care of hypertension in pregnancy is a complex interaction of social beliefs (use of herbal remedies, TBAs, gender roles in society), poverty (despite care being free at the point of need, in theory) and the adequate provision of western healthcare (both manpower and facilities). Tackling one without the others is unlikely to produce sustained benefit, however, there is significant opportunity to improve outcomes with a multifactorial approach.
Disclosure: None Introduction: Current guidance encourages clinicians to counsel living kidney donors that blood pressure may rise following nephrectomy [1, 2] . A meta-analysis estimated an increase of 6 mmHg in systolic and 4 mmHg in diastolic blood pressure five years after donation [3] . There are however, few long term prospective controlled studies.
Methods: Living kidney donors and healthy controls recruited to the CRIB-DONOR study between 2011 and 2013 were followed up at 5 years [4] . Participants underwent 24-hr ambulatory blood pressure, augmentation index and pulse wave velocity using the Mobli-O-Graph®.
Results: Ninety four patients consented (n = 92 valid day recordings, n = 74 valid night recordings). 5 There
Measures of arterial stiffness were also comparable between the two groups. Pulse wave velocity was not significantly different in donors compared to controls 7.63 ± 1.52 vs 7.27 ± 1.52 m/s, p = 0.242. There was also no difference in augmentation index (corrected to 75 beats per minute) between donors and controls 23.14 ± 8.06 vs 21.82 ± 8.22%, p = 0.441.
Conclusions: In this small cohort kidney donors and clinicians can be reassured that there is no significant rise in blood pressure or change in arterial function.
Disclosure: No conflicts of interest. [1] [2] [3] . Blood pressure, however, at least in the short term, does not appear to change [1, 4] . In chronic kidney disease nocturnal blood pressure is a superior predictor of cardiovascular mortality than day or 24-h blood pressure results [5] . We sought to investigate whether there are changes in nocturnal dipping and blood pressure variability in donors.
Methods: Healthy controls and living kidney donors recruited to the CRIB-DONOR study were followed up at 5 years. 1 All participants underwent 24-h ambulatory blood pressure recordings using the Mobli-O-Graph®. Nocturnal profiles were defined according to the percentage decline in blood pressure (<0% inverted; <10% Non-dipper; <20% Normal; >=20% extreme).
Blood pressure variability was calculated using previously published calculations for average real variability, weighted blood pressure and day-night difference [6] [7] [8] . Recordings with a gap of greater than two hours of consecutive recordings were excluded from variability analysis.
Results: A total of 94 patients consented with 74 adequate night recordings for analysis [9] . There was no significant difference in nocturnal dipping in systolic blood pressure between donors and controls 11.20 ± 5.53 vs 9.27 ± 6.20%, p = 0.381. There was also no significant difference in nocturnal dipping in diastolic blood pressure between donors and controls 14.62 ± 5.87 vs 13.40 ± 5.81%, p = 0.162.
Only 6/41 (14%) of donors had non-dipping or inverted profiles, the majority were normal. There was no difference in nocturnal profiles, average real variability, weighted blood pressure variability or day night difference between donors and controls.
Conclusions: Based on these results with a modest sample size donors can be reassured that there is little evidence of abnormal nocturnal profiles or blood pressure variability at 5 years.
Disclosure: No conflicts of interest.
P-11
Home blood pressure measurement in the treatment in morning vs. evening (TIME) study Introduction: The Treatment in Morning vs Evening (TIME) study is a large online prospective study comparing cardiovascular outcomes in 21,104 hypertensive people randomised to taking their usual anti-hypertensive medications in either the morning or the evening [1] . The study began in 2011 and continues in follow-up. Participants who reported owning their own home blood pressure monitor (HBPM) were invited to submit HBPM measurements at intervals throughout the study. We describe the home BP data collected in the TIME study.
Methods: TIME study participants who agreed to submit HBPM measurements were asked to submit sets of measurements (comprising 3 measurements, morning and evening, for 4-7 days) at baseline, 1 month, and 3 monthly thereafter. Data were entered directly into the study database by participants via a secure webpage. Means were compared using dependent t-testing (R version 3.5.2).
Results: 11,166 TIME participants were willing to submit HBPM measurements and 11,126 submitted any HBPM data. Participants have so far submitted a median of 4 sets of HBPM measurements (range 0-26). 6484 participants continue to submit regular sets of measurements. 6946 participants (62.4%) submitted sufficient data to calculate mean baseline morning and evening blood pressures. Mean overall BP at baseline was 133/77(± 12/8)mmHg (132/78 morning, 133/77 evening). 63.1% of participants reported baseline systolic BP of <135 mmHg. Mean overall BP at 2 years was 130/76(±11/8)mmHg with 70% <135 mmHg systolic. On average, systolic BP at 2 years was significantly lower than at baseline (t = −8.57, p < 0.05).
Conclusions: The TIME study collected HBPM data using participants' own monitors. Participants were willing and able to submit sufficient measurements to allow calculation of mean morning and evening blood pressures. These data will allow further insight into the outcomes of the TIME study.
Disclosure: The TIME study is funded by the British Heart Foundation and supported by the BIHS.
References: Results: FH− and FH+ had similar mean ABP (mABP: 78.5 ± 3.2 vs 83.6 ± 3.4mmHg) and respiration (15.7 ± 1.3 vs 16.2 ± 0.7 breaths/min) at rest. Slow breathing increased BRS during up-sequences in FH+ (1.2 ± 0.06 to 1.3 ± 0.06*ms/mmHg, *: P < 0.05), but not FH− (1.21 ± 0.08 to 1.35 ± 0.09ms/mmHg), and increased the low/high power ratio (LF/HF) of HRV in FH+ by increasing LF (28.1 ± 4.9 to 72.1 ± 4.4*%) and decreasing HF (37.7 ± 5.1 to 18.0 ± 2.7*%), but by increasing LF only in FH− (LF: 30.2 ± 2.9 to 62.0 ± 5.8*%; HF: 29.9 ± 6.1 to 24.6 ± 5.7%). During mental stress, BRS during up-sequences was decreased in both FH+ and FH−, but, BRS tachycardia during squatstand was decreased in FH− only (FH− 0.64 ± 0.05 vs 0.26 ± 0.11*; FH+ 0.48 ± 0.06 vs 0.46 ± 0.09 ms/mmHg).
Conclusions 64.5 ± 6.5 beats/min) and BRS (up-sequence: 1.1 ± 0.09, down-sequence: 1.2 ± 0.05 vs. 1.2 ± 0.04 and 1.3 ± 0.06 ms/ mmHg). However, low/high frequency power ratio (LF/HF) was 1.4 ± 0.05 in WEs (34.0 ± 6.2%/28.4 ± 5.1%), but only 0.7 ± 0.1 in SAs (26.5 ± 1.7 %/ 41.7 ± 4.3 %), the HF component tending to be greater in SAs (P = 0.07: SAs vs. WEs). Mental stress evoked similar increases in mABP and HR, but BRS was less depressed in SAs than WE especially during down-sequences (to 0.69 ± 0.11 vs. 1.03 ± 0.05* ms/mmHg, *: P < 0.05, WE vs. SA), while LF was increased in both SAs and WEs (to 42.9 ± 5.9* and 42.8 ± 4.8 %), but HF was decreased in SAs only (to 29.0 ± 3.4* %). Further, immediately following mental stress, BRS during squat-stand was depressed in WEs, but not SAs (0.6 ± 0.04 to 0.3 ± 0.09* vs. 0.6 ± 0.09 to 0.5 ± 0.11 ms/mmHg.
Conclusions Introduction: Sphygmomanometer cuff construction has significant effects on cuff pressure transmission to the underlying artery using Finite Element Analysis [1] . We therefore created an anthropomorphic perfused model arm to simulate the effects of different cuffs on the pressures at which blood flow may return during deflation.
Methods: A cylindrical vulcanised silicone rubber mandrel (circumference 28 cm, length 30 cm) with a metal "humerus" and silastic artery, with similar visco-elastic properties to a human arm was perfused with a 35% glycerine-in-water solution of similar viscosity to human blood using a peristaltic pump delivering a continuous flow of 160 ml/min (equivalent to brachial artery flow) at 130 mmHg. 37 examples of 8 different cuffs of similar size were inflated around the mandrel to 350 mmHg and then deflated at 2-3 mmHg/s to zero. The cuff pressures at interrupted return-to-flow (RtF), at the point of reappearance of continuous uninterrupted but pulsatile flow (PF) and of continuous non-pulsatile flow (CF) were also assessed (which may approximate to K1, K4 and K5 respectively). The physical characteristics of each cuff: elasticity, flexural rigidity and material thickness were assessed.
Results: There are very significant differences in cuff materials and their resultant physical characteristics. RtF pressures were much higher than perfusion pressure (mean 286, range 275-298 mmHg) and differed between cuffs of similar size but dissimilar construction. The highest RtF pressure was observed in a rubber-bladdered cuff with a woven sleeve and the lowest in a bladderless woven cuff. PF and CF pressures also varied between cuffs but with less variability than RtF (13 and 15 cf. 23 mmHg) and not in the same order.
Conclusions: Differing cuff construction affects the pressure at which flow returns in a perfused model arm. It cannot therefore be assumed that all cuffs of similar size give equivalent blood pressure values.
Disclosure: Introduction: There are limited data regarding the clinical use of home BP monitoring in infants and young children and older children unable to tolerate 24-h ambulatory BP monitoring (ABPM). We taught parents to perform home doppler assisted systolic BP monitoring (HDBPM) using aneroid sphygmomanometer [1] .
Methods: Retrospective review over a 5-year period of all children referred to our tertiary hypertension service in whom parents/carers performed HDBPM. During a planned hospital appointment, parents were shown how to perform HDBPM with monitoring performed over at least two weeks with three measurements in quick succession performed twice a day.
Results: 116 children underwent HDBPM with median (IQR), 2.25 (0.83-4.9) years, including 29.5% (n = 34), 30% (n = 35), 22.5% (n = 26) and 18% (n = 21) in children aged ≤1, 1− ≤2, 2 years-≤5 and >5 years old respectively. HDBPM was used as the children were too young 69% (n = 80) or thought unlikely to be able to tolerate ABPM in 31% (n = 36) as a result of underlying learning difficulties or neurological disease. Underlying primary diagnosis was renal in 44.8% (n = 52), and non-renal in others. Children had been referred to our service for confirmation of hypertension, 51.7% (confirmation group, n = 60/116) or for monitoring of BP levels 48.3% (monitoring group, n = 56) for those on anti-hypertensive therapy. In the confirmation group, 90% (n = 54/60) were found to be normotensive and only 10% (n = 6/60) to have confirmed hypertension. In the monitoring group, 94.6% (n = 53/56) were found to be non-hypertensive, of whom n = 3 weaned dose and n = 13 stopped antihypertensive medication whilst HDBPM. 5.4% (n = 3) were found to have uncontrolled hypertension. None of the children required admission to hospital to manage their hypertension.
Conclusions: HDBPM is acceptable to children and their families; we demonstrate its feasibility as an out-of-office measurement technique in young children and those in whom ABPM is not possible.
Disclosure Introduction: There should be a manual BPM machine in every hospital inpatient ward [1] and all BPMs should be validated. Previous studies have demonstrated poor maintenance of BPMs and cuffs in this setting. We aimed to assess compliance with BIHS guidelines [2] in a large District General Hospital (DGH).
Methods: All manual and automated BPMs and cuffs were assessed in the medical, surgical and maternity wards of a large DGH. Each BPM was checked against the BIHS and dabl® Educational Trust [3] lists of validated BP machines and for function, range of cuff sizes available, cuff attachments, state of Velcro®, state of connecting tubes, inflation bulbs and valves and for the presence of any air pressure leaks.
Results: A total of 127 BPMs were assessed. All the manual machines (Accoson Greenlight 300) were validated by the BIHS but none of the automated machines had BIHS or dabl® Educational validations. Of 99 machines on medical and surgical wards, 81% were automated and 19% manual. On maternity wards, 64% were manual and 36% automated. Two or more cuffs of different sizes were available on 41% of the 37 manual BP monitors and on 62% of the 90 automated BP machines. Faults were present in 9 out of 37 manual BP monitors (missing connectors 2, defective inflation valves 4, faulty bulbs 3) and in 12 out of 90 automated BP monitors (not working despite battery being charged 4, no cuff attachments 6, not working 4, Velcro® not holding 2).
Conclusions: All manual machines but none of the automated machines were validated. There was an inadequate range of cuffs available. Maintenance of BPMs, their cuffs and attachments was unsatisfactory. Guidelines for purchase and provision of BPMs with an appropriate range of cuffs as well as for their routine maintenance are required [4] .
Disclosure: Introduction: The risk of cardiovascular disease (CVD) increases in women with a history of hypertensive disorders of pregnancy (HDP). Although the mechanisms exploring this association are poorly understood, a reduction in skin capillary density or capillary rarefaction (CR), has been proposed in its pathogenesis. CR precedes the onset of pre-eclampsia (PE) and essential hypertension. Hence, this study aimed to investigate whether CR persists post HDP and therefore, acts as a significant risk factor for the consequent development of CVD. Methods: A total of 86 non-pregnant women were studied (mean age 37 ± 6 years). Of these, 44 had a previous history of PE (mean age 37 ± 9 years), 29 had history of gestational hypertension (GH) (mean age 37 ± 6 years) and 13 were healthy controls (mean age 35 ± 5 years). We measured central systolic blood pressure (cSBP), aortic augmentation index (AIx), pulse pressure (PP) and capillary density on the dorsum of the middle finger using noninvasive intra-vital capillaroscopy.
Results: GH group had higher cSBP (128.93 ± 10.3 mmHg vs 111.15 ± 11.02 mmHg, p < 0.0001), SBP (124.66 ± 8.7 mmHg vs 109.81 ± 11.1 mmHg, p = 0.001) DBP (76.33 ± 9.0 mmHg vs 67.8 ± 8.4 mmHg, p = 0.025) and PP (48.3 ± 8.6 mmHg vs 41.9 ± 4.5 mmHg, p = 0.031), compared to controls. GH also had a higher SBP (mean difference 7.5mmHg, 95%CI 0.84 to14.23 mmHg, p = 0.022) and PP (mean difference 6.26 mmHg, 95%CI 2.01 to 10.51 mmHg, p = 0.002) compared to PE. Moreover, PE group had higher cSBP (mean difference 11.63 mmHg, 95%CI 1.76 to 21.50 mmHg, p = 0.015) compared to controls. No significant differences were seen in AIx or capillary density between groups.
Conclusions: Women with a history of GH are more likely to have systemic arterial stiffness, as a result of raised cSBP, PP and SBP, compared to women with history of PE and healthy controls. Further larger studies are needed to characterise the role of microcirculation in the causation of long-term increased risk of CVD in women with a history HDP.
Disclosure: None National Heart, Lung, and Blood Institute, Bethesda, MD, USA Introduction: The relationship between coronary artery calcium score (CAC), a marker of epicardial coronary artery disease, blood pressure (BP) and hyperaemic myocardial blood flow in asymptomatic people with type 2 diabetes (T2D) and no prior history of cardiovascular disease is unknown.
Methods: We prospectively enrolled adults with T2D and healthy controls, with no history of cardiovascular disease. Subjects underwent bio-anthropometric profiling, 24h ambulatory BP monitoring, CT CAC and adenosine stress cardiac MRI with automated inline myocardial blood flow quantification [1] . Subjects with reversible perfusion defects were excluded.
Results: A total of 40 people with T2D (age 65 ± 7 years, BMI 31 ± 6kg/m 2 , HbA1c 7.2 ± 0.9%) and 11 healthy controls (age 59 ± 8 years, BMI 26 ± 3 kg/m 2 , HbA1c 5.6 ± 0.3%) were included. Mean 24 h systolic blood pressure was higher in people with T2D than controls (127 ± 9 vs 115 ± 8 mmHg, respectively, p = 0.007) but there was no difference in mean 24h diastolic blood pressure (p = 0.782). Coronary artery atherosclerotic burden was higher in T2Ds compared with controls (total CAC 310 ± 569 vs 86 ± 175, respectively, p = 0.043). Global stress myocardial blood flow was lower in T2Ds than in controls (1.7 ± 4.7 vs 2.0 ± 3.8 mL/g/min, respectively, p = 0.045), but there was no difference in resting myocardial blood flow (p = 0.629) between groups.
In those with T2D, total CAC was the only univariable predictor of global stress myocardial blood flow, with which it showed an inverse correlation (r = −0.396, p = 0.015). In a multivariable model containing age, gender, mean 24h systolic blood pressure and CAC, CAC was the only independent predictor of global stress myocardial blood flow (β = −0.373, p = 0.045).
Conclusions: In asymptomatic people with T2D and no reversible perfusion defects, CAC but not blood pressure is an independent determinant of stress myocardial blood flow. Non-obstructive epicardial coronary disease should therefore be accounted for when assessing the potential causes of microvascular dysfunction in these patients.
Disclosure: None References: Introduction: The association between hyperuricaemia and hypertension has been reported. However, previous studies demonstrated no association between hyperuricaemia and hypertension in patients with psoriasis. This current study aims to determine whether there is an association between hyperuricaemia and hypertension in a cohort of patients with psoriatic arthritis, a condition in which hyperuricaemia is a comorbidity.
Methods: The medical notes of 73 patients aged 25-88 years (24 males and 57 females) with psoriatic arthritis at the Central Middlesex Hospital were checked for hyperuricaemia and hypertension. The subjects were 40 Caucasians, 27 Indo-Asians and 6 Afro-Caribbean. Patients were considered hypertensive if they were on anti-hypertensive medication or had elevated blood pressure recordings. A chi-squared statistical test was conducted using IBM's SPSS software.
Results: Of the 73 patients, 9 had hyperuricaemia. Proportionally, 50% of the hyperuricaemic patients (n = 6) were hypertensive. 19% of patients with hypertension had hyperuricaemia compared to 7% of the normotensive. Despite that chi-squared test was non-significant (p = 014). There was no gender or ethnic differences in the results.
Conclusions: In this pilot study, there is no association between hypertension and hyperuricaemia in psoriatic arthritis patients. This is similar to the previously published results showing no association between hyperuricaemia and hypertension in patients with psoriasis. There was no gender or ethnic preferences in the results. Further studies with a larger sample size are suggested.
Disclosure: None University of Warwick, Warwick, United Kingdom Introduction: Treatment-resistant hypertension (TRH) is present in around 10 percent of the patients with treated hypertension. Its prevalence is often overestimated, a consequence of failure to exclude non-adherence and white coat hypertension. We aim to describe phenotypical and biochemical characteristics of TRH in the first 100 patients recruited to FACT-RHY study (a study of Factors AssoCiated with Treatment Resistant HYpertension).
Methods: Patients aged 18-80 years with treated hypertension and without any confirmed causes of secondary hypertension were eligible. All patients gave written consent to attend the study visit where detailed clinical history, examination, biochemical and physiological testing was performed. Patients with uncontrolled blood pressure (average BpTRU >140/90) taking ≥3 antihypertensives or if BP controlled on ≥4 agents and in both case at least 3 antihypertensives must be detectable by urine antihypertensive assay. All other patients were defined as a control group.
Results: Forty-one patients had TRH, 53 were females and 51 Caucasians. Patients with TRH were older, had significantly higher waist-hip and waist-height ratios, a longer duration of hypertension and, higher prevalence of left ventricular hypertrophy and diabetes mellitus compared to controls. Patients with TRH were prescribed a higher number of antihypertensives and other medications including diuretics and lipid-lowering therapy. Biochemical testing showed that a lower estimated glomerular filtration rate and serum album and a higher kappa-lambda ratio, NTproBNP, high-sensitivity Troponin I and aldosterone-renin ratio were associated with TRH. There were no differences in urinary albuminuria, 24-h urinary catecholeamines and metadrenalines and daily salt intake estimated from 24-h urinary sodium excretion. The 10-year Qrisk2 was significantly higher at 21.0% in TRH compared to 7.6% in controls.
Conclusions: Patients with TRH have significantly higher comorbidities and medication burden culminating in a higher prevalence of target-organ damage and consequently a higher future risk of cardiovascular and cerebrovascular disease.
Disclosure: None P-25 Evaluation of vascular endothelial dysfunction through measurement of serological biomarkers and reactive hyperaemia index in patients with true-treatment resistant hypertension 3 Aston University, Birmingham, United Kingdom, 4 University of Warwick, Birmingham, United Kingdom Introduction: Association between hypertension and endothelial dysfunction is well-established. Studies have shown the presence of a higher degree of endothelial dysfunction in treatment-resistant hypertension (TRH). We aim to assess and compare endothelial dysfunction, by measuring levels of vascular biomarkers and reactive hyperaemia index (RHI), in patients with true TRH and non-TRH controls in the first 100 patients recruited to FACT-RHY study (a study of Factors AssoCiated with Treatment Resistant HYpertension).
Methods: Peripheral arterial tone (PAT) was measured pre and post complete brachial arterial occlusion for 5 min using EndoPAT. The RHI is the post-to-pre occlusion PAT signal ratio in the occluded arm, relative to the same ratio in the control arm, corrected for baseline vascular tone of the occluded arm. Enzyme-linked immunosorbent assay was used to measure levels of sFlt-1, ICAM-1, VCAM-1, endothelin-1, and endoglin. Patients with adherenceconfirmed TRH (either uncontrolled BP on ≥3 agents or controlled BP on ≥4 agents) were compared against a control group.
Results: Forty-three patients underwent EndoPAT assessment and biomarkers were measured in all patients. There was no significant difference in the proportion of patients with abnormal RHI in patients with TRH compared to controls; 7 (41.2%) and 8 (30.7%) respectively (p = 0.528). Median (interquartile range) serum endothelin-1 concentration was significantly higher in the TRH group compared to control group; 1.98 (1.61-2.38) pg/mL and 1.81 (1.40-2.26) pg/mL (p = 0.001). Median concentration of VCAM-1 was higher in the TRH group at 1136.9 (1024.0-1229.7) ng/mL compared to the control group at 1049.0 (956.3-1131.6) ng/mL (p = 0.017). There was no significant difference in serum concentrations of sFLT-1, endoglin, and ICAM-1 in the two groups. No significant correlations were present between RHI and the biomarkers.
Conclusions: Serum endothelin-1 and VCAM-1 were found to be higher suggesting higher level of endothelial dysfunction in patients with TRH.
Disclosure: None P-26 Assessment of fluid excess and body composition using bioimpedance spectroscopy in patients with adherence-proven treatment-resistant hypertension Introduction: Fluid retention has been shown to be a predominant factor in the development of treatment-resistant hypertension (TRH) and has been successfully shown to be an important therapeutic target with diuretics such as aldosterone receptor antagonists. We aim to assess fluid excess and body composition using bioimpedance spectroscopy in the first 100 patients recruited to FACT-RHY study (a study of Factors AssoCiated with Treatment Resistant HYpertension).
Methods: All patients with treated hypertension without any confirmed causes of secondary hypertension underwent bioimpedance spectroscopy using the Fresenius Body Composition Monitor (BCM), which has been validated against gold standard reference methods to assess fluid excess in patients with end-stage renal disease. Patients with adherence-confirmed TRH (either uncontrolled BP on ≥3 agents or controlled BP on ≥4 agents) were compared against a non-TRH control group of patients.
Results: Forty-one patients with TRH and 59 patients with treated hypertension underwent bioimpedance spectroscopy. The mean absolute fluid excess, in litres, was higher in the TRH compared to controls but did not reach statistical significance. The BCM identified only 5 patients with absolute fluid excess (>1.1L) overall, 3 of whom had TRH. Interestingly, however 47% were found to be underhydrated (<−1.1L) and the remaining 48% normally hydrated. Another measure of hydration, extracellular water to intracellular water ratio, was higher in the TRH group compared to controls; 0.86 (0.09) and 0.82 (0.07) respectively (p = 0.013). Fluid excess correlated negatively with serum albumin and measured daily salt intake, and positively with aldosterone-renin ratio and urine albumincreatinine ratio. Lean tissue index and fat tissue index did not differ significantly in the two study groups.
Conclusions: Although some measures suggest fluid excess was higher, generally more patients were found to be underhydrated which may be a consequence of high diuretic use in the TRH group.
Disclosure: None Introduction: Aortic stiffness as quantified by carotid-tofemoral pulse wave velocity (cfPWV) is considered a gold standard marker of asymptomatic organ damage in hypertension. There is no clear evidence to suggest that patients with treatment-resistant hypertension (TRH) have an increased PWV compared to non-TRH patients with studies reporting both higher and no difference in PWV. We aim to compare the cfPWV in TRH and non-TRH controls in the first 100 patients recruited to FACT-RHY study (a study of Factors AssoCiated with Treatment Resistant HYpertension).
Methods: All patients with treated hypertension without any confirmed causes of secondary hypertension underwent pulse wave analysis and cfPWV measurements using the Vicorder system. Patients with TRH (either uncontrolled BP on ≥3 agents or controlled BP on ≥4 agents) were compared against a non-TRH control group of patients.
Adherence to antihypertensives was confirmed using urine antihypertensive assay.
Results: Both central and peripheral pulse pressures were significantly higher in the patients with TRH compared to controls. Augmentation index, either alone or adjusted to a heart rate of 75 beats per minute, was not found be significantly different in the two groups of patients. Mean cfPWV was significantly higher in patients with TRH when compared to controls; 10.0 ± 2.2 m/s and 8.8 ± 2.1 m/s respectively (p = 0.008). Univariate correlations of study parameters with cfPWV showed a strong positive correlation between increasing age and cfPWV (r = 0.527 p < 0.001). Gender, ethnicity, BMI and smoking status had no significant correlation with cfPWV, whilst smoking pack years, longer duration of hypertension, presence of diabetes mellitus, peripheral systolic BP and mean arterial pressure had significant positive correlation with cfPWV.
Conclusions: Patients with TRH were found to have a higher cfPWV with a relatively strong positive correlation with age and peripheral systolic BP.
Disclosure: None Introduction: Non-adherence to antihypertensive medications is common in patients with treatment-resistant hypertension (TRH) and is present in up to 50%, the reasons for which are multifactorial. We aim to assess patients' beliefs about medications and their association with adherence status and TRH in first 100 patients recruited to the FACT-RHY (a study of Factors AssoCiated with Treatment-Resistant HYpertension) study using the beliefs about medicines questionnaire (BMQ). The BMQ has been showed to be associated with adherence in numerous chronic illnesses.
Methods: The BMQ comprises 18 statements, divided into 4 subscales, each is rated on a five-point Likert scale. The scores from the Likert scale (strongly-agree, agree, uncertain, disagree, strongly-disagree) are aggregated for each subscale with the highest score indicating stronger beliefs. Specificnecessity and specific-concern subscales assess patients' beliefs about the necessity of and their concerns about the potential adverse-effects of taking antihypertensive medications. General-overuse and general-harm subscales evaluate patients' views about how doctors use medications and the extent to which they perceive medications as harmful.
Results: All 100 patients attending the study visit completed the BMQ. Sixty patients were found to be adherent to 80% of the antihypertensives prescribed that were detectable on urine antihypertensive assay. The Chronbach's alpha for specific-necessity, specific-concerns, generaloveruse and general-harm subscales were 0.83, 0.71, 0.77 and 0.68 respectively. In unadjusted analysis, none of the 4 subscales were associated with adherence status. In logistic regression analysis general-overuse and generalharm subscales were independently associated with nonadherence. Mean scores for specific-necessity, specificconcerns and general-overuse subscales were significantly higher in TRH patients compared to controls.
Conclusions: Our study suggests that patients with TRH believe that their medicines are necessary which outweigh their concerns about taking medicines. Furthermore, patients' perceptions of medicines as being harmful and their overuse by doctors was associated with nonadherence.
Disclosure: None Introduction: Leptin (LPT) is associated with cardiovascular risk factors (e.g. hypertension, kidney disease, insulin resistance and excess body weight). Experimental studies showed that LPT might affect serum uric acid (SUA), by modulation of the SUA excretion. However, there are few observational data on the relationship between LPT and SUA in general population. Therefore, the aim of the present study was to evaluate the relationship between LPT and SUA and its excretion in a large middle-aged male general population.
Methods: A sample of 930 adult male individuals (mean age: 52 years) without therapy for high SUA was included in the analysis (the Olivetti Heart Study).
Results: SUA was significantly and positively associated with LPT, BMI, waist circumference, blood pressure, insulin resistance and C-reactive protein (p < 0.01), while inversely with renal function (p = 0.01). The multivariate analysis confirmed the association between LPT and SUA after adjustment for potential confounders (p < 0.01). This trend was also detected for normal weight and excess body weight participants, separately. Moreover, LPT was inversely associated with excretion of SUA (p < 0.01), also in multivariate analysis (p = 0.03).
Conclusions: The results of this study indicate a positive association between circulating LPT levels and SUA, independently of main potential confounders, both in normal weigh and excess body weight men. Furthermore, these findings suggest an inverse relationship between LPT and SUA excretion.
Disclosure: All authors declare that they have no conflict of interest. Introduction: High sodium (Na) and inadequate potassium (K) intake are important determinants of high blood pressure (BP) and cardiovascular diseases (CVDs), as well as iodine deficiency is a public health problem. CVDs are the leading cause of morbidity and mortality in the Republic of Moldova. There is no reliable measure of Na, K and iodine intake in Moldova. The aim of the present survey was to establish current baseline average consumption of Na, K and iodine in a random sample of men and women in Moldova.
Methods: The survey sample was randomly selected by the National Bureau of Statistics to be nationally representative. Participants attended a screening including demographic, anthropometric and physical measurements by standardized methods. Dietary Na (salt), K and iodine intakes were assessed by 24 h urinary Na (UNa), K (UK) and iodine (UI) excretions. Urinary creatinine was measured to evaluate the completeness of the urine collection.
Results: Eight hundred and fifty-eight (326 men, 18-69 years) were included in the analysis (response rate 66%). Mean UNa was 173 (±79 SD) mmol/day, equivalent to 10.8 g of salt/day, and K excretion 73 (±31) mmol/day, equivalent to 3.7 g/day. Only 11% had a salt intake below the WHO recommended target of 5 g/ day, and 50% ate enough K (>90 mmol/day). Mean UI was 225 (±152) mcg/24 h, 41% had adequate iodine intake, whilst 29% were still deficient and 30% had excessive intake. The prevalence of hypertension (BP>140/90 mmHg or on anti-hypertensive medications) was 45.5%, with no difference between sexes. Twothirds of responders (74.3%) were not taking medications and had raised BP, with higher prevalence in men (82.4%) compared to women (69.2%).
Conclusions: There is need for intensive awareness campaigns and health promotion to improve the take up of preventive strategies aiming at reducing salt consumption and increasing potassium and iodine intake in the Republic of Moldova. Furthermore, the level of untreated hypertension is still high, particularly in men.
Disclosure: None P-31 Predicting adverse responses to physical activity in young adults with suboptimal blood pressure Introduction: In a population, greater physical activity is associated with lower blood pressure (BP) but, for an individual, significant heterogeneity in experience and BP response to exercise is observed [1] . We hypothesised certain cardiovascular phenotypes associated with suboptimal BP may result in adverse responses to acute and/or chronic exercise. Our objective is to perform multi-modality deepphenotyping in a cohort of young adults with a range of BP to investigate variation in cardiac response to exercise and identify baseline predictors of response to exercise interventions.
Methods: 146 young adults (27 ± 5 years) with a range of BP were recruited between 2011 and 2016 to undergo cardiac, vascular and brain magnetic resonance imaging, lifestyle and psychological assessment (including 7 day accelerometery) and blood sampling. A sub-group (n = 71) underwent cardiopulmonary exercise testing with stress echocardiography to assess the myocardial response to exercise at 40%, 60%, and 80% of peak exercise load as well as biochemical response to exercise (e.g. plasma copeptin release).
Results: Participants with suboptimal BP (128.8 ± 9.5/ 76.7 ± 7.98 mmHg) showed higher left ventricular mass indexed to end-diastolic volume (P = 0.007) and lower longitudinal systolic strain when compared with optimal BP participants (109.7 ± 6.46/66.4 ± 5.65). During exercise the suboptimal group had a smaller increase in ejection fraction up to 40% workload (P < 0.001) (Fig. 1) and achieved ejection fraction at 40% workload inversely associated with the post-exercise physiological stress marker, plasma copeptin (r 2 = 0.115, P = 0.043). The suboptimal BP group reported greater exertion on exercise and lower enjoyment of physical activity. Introduction: Prevalence of cardiovascular disease (CVD) including hypertension is higher in South Asians (SAs) than White Europeans (WEs). This has been associated with endothelial dysfunction, diabetes and obesity 1 . Whether endothelial dysfunction is present in young SA women and whether vasodilator prostaglandins might protect them is unknown.
Conclusions
Methods: Arterial blood pressure (ABP), forearm blood flow (FBF), forearm vascular conductance (FVC: FBF/ ABP) were recorded in 8 SA and 8 WE women (student volunteers; 20 ± 0.5; 20 ± 0.3 years) at rest and following 2 min arterial occlusion (reactive hyperaemia) and 2 min rhythmic contractions at 30 and 60% maximum voluntary contraction (MVC) after placebo and after cyclooxygenase inhibition (aspirin 600 mg p.o).
Results: In SAs vs WEs, resting ABP was 120 ± 4.3/73 ± 3.6 vs 114 ± 3.1/73 ± 2.7mmHg, BMI: 26 ± 2. , women were also split by BMI irrespective of ethnicity. In high BMI women, COX inhibition attenuated exercise hyperaemia at 60%MVC, but had no effect on reactive hyperaemia or exercise hyperaemia at 30%MVC, whereas in normal BMI women, COX inhibition attenuated reactive and exercise hyperaemia at 30 and 60%MVC.
Conclusions: In young SA women, endotheliumdependent reactive and exercise hyperaemia are blunted with a depressed contribution of vasodilator prostaglandins. This may be attributed to their higher BMI and predispose them to CVD.
Disclosure: The relationship between body size and blood pressure (BP) is well recognized. Body size also associates with cardiac output (CO)-the key haemodynamic determinant of BP in young adults. However, it is unclear whether fat mass or lean mass primarily associates with BP and its determinants, since lean mass also increases in obesity. The aim of this study was to examine the relationship between elements of body composition, BP and its haemodynamic determinants in young adults.
Methods: In-depth phenotyping was undertaken in 271 healthy individuals (153 males; 28 ± 6 years) across a range of body size and BP levels. Body composition was assessed using electrical bioimpedance; CO and stroke volume (SV) using inert gas rebreathing. Peripheral vascular resistance (PVR) was calculated from CO and mean arterial pressure (MAP). All analyses were conducted separately for males and females.
Results ) and heart rate (β = 0.71; beats/min) in females. Differences between sexes in systolic BP, diastolic BP, MAP, CO, SV and PVR were eliminated by matching for FFM, but not FM.
Conclusions: FFM is the dominant determinant of systolic BP in young adults, via increased CO and SV and reduced PVR. However, FM is the dominant determinant of diastolic BP and MAP. The impact of lean mass on BP elevation should not be overlooked in young adults.
Disclosure: None P-35 The association between obesity and arterial stiffness from adolescence through to emerging adulthood and the confounding role of blood pressure (i) indicators dependent on medication adherence (e.g. percentage of hypertensive patients with blood pressure (BP) ≤150/90 mmHg); (ii) indicators dependent on prescribing but not on adherence (e.g. prescribing antiplatelet drugs in ischaemic heat disease) or (iii) indicators unrelated to prescribing or adherence (e.g. assessment of stroke risk in atrial fibrillation). Using mixed-effects logistic regression we estimated differences between dispensing and nondispensing practices, with adjustment for percentage of practice population aged ≥65, sex, practice deprivationlist size, single-handed status and rurality.
Results: Data existed for practices; (1%). Dispensing practices had more patients aged ≥65, lower deprivation, were more often single-handed rural. Seven of nine QOF indicators dependant on adherence were better achieved in dispensing than non-dispensing practices, including greater achievement of target hypertension (Odds ratio 1.07; 95%CI 1.04-1.11, p < 0.0001). In contrast, we only found differential achievement for one of nine indicators related to prescribing but not adherence, and one of six indicators unrelated to prescribing or adherence.
Conclusions: Between 3% and 10% of prescriptions go unfilled by pharmacies. These findings offer initial evidence that dispensing practices may achieve better outcomes than prescribing practices through improved medication adherence. Further work is required to clarify the possible underlying mechanisms for these observations. Disclosure: None References:
1. Quality and Outcomes Framework (QOF)-2016-17. https://digital.nhs.uk/data-and-information/publications/sta tistical/quality-and-outcomes-framework-achievementprevalence-and-exceptions-data/quality-and-outcomes-fra mework-qof-2016-17 P-40 Antihypertensive drug concordance in patients with apparent resistant hypertension: a tertiary hypertension referral centre experience Mohammed Meher Ali Chaudhry Introduction: Individuals with resistant hypertension (RH) have a 50% greater risk of cardiovascular disease events compared to those with well-controlled hypertension [1] . Nonadherence to antihypertensive medication is a major cause of RH, with rates reported as high as 66% [2] . The aim of this study was to assess the prevalence of non-adherence in individuals with apparent RH referred to the Blood Pressure Unit at St George's University Hospital NHS foundation Trust.
Methods: After the optimisation of drug regimens and the exclusion of white coat and secondary hypertension, drug adherence was assessed using liquid chromatography-mass spectrometry analysis of urine samples in 124 individuals who met the criteria for RH. All included subjects confirmed adherence to their prescribed antihypertensive medication on several occasions, including when urine samples were obtained.
Results: Non-adherence was found in 71 individuals (57.3%). Of these, 45 (63.4%) had partial non-adherence and 26 (36.6%) had complete non-adherence. Non-adherent individuals were significantly younger, had a shorter history of hypertension, more likely to be a female (OR: 3.07; 95% CI: 1.45-6.47; p = 0.003) and have depression (OR: 11.66; 95% CI 1.47-92.19; p = 0.004), and less likely to have concomitant cardiovascular disease and/or target organ damage (OR: 0.42 95% CI 0.19-0.92; p = 0.028), type 2 diabetes mellitus (OR: 0.40; 95% CI: 0.19-0.83; p = 0.013), chronic kidney disease (OR: 0.34; 95% CI 0.12-0.92; p = 0.028) and retinopathy (OR: 0.14; 95% CI 0.04-0.51; p = 0.001). Low levels of adherence were observed more in individuals on diuretics.
Conclusions: In individuals with apparent RH, poor adherence to antihypertensive therapy is very common and was observed in 57% of individuals despite their insistence of treatment adherence in the preceding days. The assessment of adherence at an early stage in individuals with apparent RH is essential for tailoring treatment strategies and saving vital healthcare resources.
Disclosure: 4 University of Manchester, Manchester, United Kingdom, 5 Utrecht Institute of Pharmaceutical Sciences, Utrecht, The Netherlands, 6 University College London, London, United Kingdom, 7 Queen Mary University London, London, United Kingdom Introduction: The current approach to blood pressure treatment is guided predominantly by blood pressure thresholds. This is despite strong evidence that the benefits of blood pressure reduction are observed across the blood pressure spectrum and that absolute treatment benefits are proportional to pre-treatment absolute cardiovascular risk. The aim of this study was to investigate the implications of alternative strategies for offering blood pressure treatment in the UK.
Methods: This is a cohort study using data from 1.2 million UK primary care patients without cardiovascular disease (CVD), followed from 2011 for a median 4.3 years in the
